Stability Testing Services and Drug Master File Maintenance for Antibody Drug Conjugate ADCT-701
Award Notice Posted
- Solicitation number
- 75n91025NO7142309
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Awarded
- to ADC Therapeutics America, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N91025P00462 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- New Providence, New Jersey 07974, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a sole source, firm-fixed-price contract worth $194,000 to ADC Therapeutics America, Inc. for stability testing services and drug master file maintenance for the antibody drug conjugate ADCT-701. The contract was awarded on September 29, 2025, under FAR 6.302-1 authority as a non-competitive procurement, indicating that only one responsible source could satisfy the agency's requirements. This award represents specialized pharmaceutical services related to maintaining stability testing protocols and regulatory documentation for a specific therapeutic compound, with the contract being published in accordance with federal requirements for awards exceeding $25,000.
Notice text
The Department of Health and Human Services (DHHS) Office of Acquisition Management Services (OAMS) has awarded a firm-fixed-price contract for Stability Testing Services and Drug Master File Maintenance for Antibody Drug Conjugate ADCT-701.
This action was NOT competed. The contract was awarded on a sole source basis under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. This synopsis is prepared in accordance with FAR 5.301, which requires publication of contract awards exceeding $25,000.
Awarded contract 75N91025P00462 to ADC THERAPEUTICS AMERICA, INC. for 194000.00 on 2025-09-29.
Files
| File | Type | Posted |
|---|---|---|
| SSJ ADCT-705_Redacted.pdf | ||
| FedBizOpps_Award_Synopsis (002).pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity